Cargando…

ML-07 High expression of PD-L1 on tumor-associated macrophage is a predictive factor for favorable prognosis in PCNSL

PD-L1 and PD-L2 expression on tumor cells and tumor-infiltrating immune cells in primary central nervous system lymphoma (PCNSL) remains unclear. In the present study, we investigated the expressions of PD-L1 and PD-L2 in surgical specimens from needle biopsies and craniotomies to compare tumor tiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furuse, Motomasa, Kuwabara, Hiroko, Ikeda, Naokado, Hattori, Yasuhiko, Ichikawa, Tomotsugu, Kagawa, Naoki, Kikuta, Kenichiro, Tamai, Sho, Nakada, Mitsutoshi, Wakabayashi, Toshihiko, Kuroiwa, Toshihiko, Wanibuchi, Masahiko, Miyatake, Shin-Ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699119/ http://dx.doi.org/10.1093/noajnl/vdaa143.070

Ejemplares similares

PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma
por: Furuse, Motomasa, et al.
Publicado: (2020)

NI-04 WHICH RADIOLOGICAL IMAGING IS BEST TO DISCRIMINATE RADIATION NECROSIS FROM TUMOR PROGRESSION? - SUBANALYSIS OF SYSTEMATIC REVIEW FOR RADIOLOGICAL DIAGNOSIS OF RADIATION NECROSIS
por: Furuse, Motomasa, et al.
Publicado: (2019)

STMO-07 Adverse events related to the glioblastoma surgery and their perioperative management in our hospital
por: Kashiwagi, Hideki, et al.
Publicado: (2020)

Characteristic and Management of Symptomatic Septum Pellucidum Cyst in Extreme Elderly Patient: Case Report and Literature Review
por: IKEDA, Naokado, et al.
Publicado: (2022)

Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review
por: Furuse, Motomasa, et al.
Publicado: (2019)

Frameless Stereotactic Biopsy with Intraoperative Computed Tomography “Assessment of Efficacy and Real Target Registration Error”
por: IKEDA, Naokado, et al.
Publicado: (2022)

Identification of early and distinct glioblastoma response patterns treated by boron neutron capture therapy not predicted by standard radiographic assessment using functional diffusion map
por: Hiramatsu, Ryo, et al.
Publicado: (2013)

Fluoroscopic-Guided Paramedian Approach for Lumbar Catheter Placement in Cerebrospinal Fluid Shunting: Assessment of Safety and Accuracy
por: Tucker, Adam, et al.
Publicado: (2019)

Long-Term Prognosis of Cognitive Function in Patients With Idiopathic Normal Pressure Hydrocephalus After Shunt Surgery
por: Kambara, Akihiro, et al.
Publicado: (2021)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

The roles of platelet-derived growth factors and their receptors in brain radiation necrosis
por: Miyata, Tomo, et al.
Publicado: (2014)

Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report
por: FURUSE, Motomasa, et al.
Publicado: (2017)

ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL
por: Ohka, Fumiharu, et al.
Publicado: (2021)

Influence of surgical position and registration methods on clinical accuracy of navigation systems in brain tumor surgery
por: Furuse, Motomasa, et al.
Publicado: (2023)

Pathophysiology, Diagnosis, and Treatment of Radiation Necrosis in the Brain
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2015)

Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas
por: Furuse, Motomasa, et al.
Publicado: (2015)

Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis
por: Yoritsune, Erina, et al.
Publicado: (2014)

Skull Bone Regeneration Using Chitosan–Siloxane Porous Hybrids—Long-Term Implantation
por: Shirosaki, Yuki, et al.
Publicado: (2018)

ML-17 Clinical usefulness of Tirabrutinib in recurrent PCNSL: single institute experience
por: Matsuura, Jin, et al.
Publicado: (2021)

ML-13 AN ATTEMPT OF RECHALLENGE OF HD-MTX AND MAINTENANCE THERAPY OF MTX FOR PATIENTS WITH PCNSL
por: Yamaguchi, Takashi, et al.
Publicado: (2019)

ML-5 THE TRANSITION OF THE TREATMENT OF 60 PCNSL CASES AT OUR INSTITUTION AND CLINICAL CONSIDERATIONS
por: Yoshitake, Hidenobu, et al.
Publicado: (2022)

ML-4 POLICY CHANGE TO PCNSL TREATMENT LED BY HEMATOLOGY, AND INITIAL TREATMENT RESULTS
por: Hashiba, Tetsuo, et al.
Publicado: (2022)

ET-9 Development of photosensitive antibodies for near-infrared light immunotherapy targeting EGFR and IL13Rα2 of malignant gliomas and investigation of their photodynamic cytotoxic activity in vitro
por: Nonoguchi, Naosuke, et al.
Publicado: (2021)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

ML-13 The primary treatment outcomes and future problems of PCNSL elderly patients in our institute
por: Kambe, Atsushi, et al.
Publicado: (2020)

ML-09 The REAL-WORLD of Elderly PCNSL Therapy in Tohoku and Niigata Area According to Retrospective Analysis: A Collaborative Investigation of the Tohoku Brain Tumor Study Group
por: Asano, Kenichiro, et al.
Publicado: (2020)

Chronic pathophysiological changes in the normal brain parenchyma caused by radiotherapy accelerate glioma progression
por: Tsuji, Yuichiro, et al.
Publicado: (2021)

ML-14 Re-challenge and maintenance therapy of methotrexate for elderly PCNSL patients with low scored KPS
por: Yamaguchi, Takashi, et al.
Publicado: (2020)

ML-12 Clinical impact and management of skin-related disorders during treatment of relapsed PCNSL by tirabrutinib
por: Sasaki, Nobuyoshi, et al.
Publicado: (2021)

Transporter-Mediated Drug Interaction Strategy for 5-Aminolevulinic Acid (ALA)-Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors
por: Ishikawa, Toshihisa, et al.
Publicado: (2011)

Chronic expanding pituitary hematoma with calcification resulting from pituitary adenoma: illustrative case
por: Takagi, Fugen, et al.
Publicado: (2023)

Treatment outcome and prognostic factors in PCNSL
por: Niparuck, Pimjai, et al.
Publicado: (2019)

Pituitary stone resulting in visual dysfunction and spontaneous rhinorrhea in nonfunctioning pituitary adenoma: illustrative case
por: Kanemitsu, Takuya, et al.
Publicado: (2021)

ET-5 Biological effects of simultaneous use of multiple drugs in neutron capture therapy using rat brain tumor model
por: Kawabata, Shinji, et al.
Publicado: (2021)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

ML-12 HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDC-ASCT) FOR THE PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
por: Miyakita, Yasuji, et al.
Publicado: (2022)

Bilateral Posterolateral Sulcus Approach for the Removal of Spinal Intramedullary Metastatic Adenocarcinoma: A Technical Case Report
por: TSUJINO, Kohei, et al.
Publicado: (2022)

Anatomical Limitation of Posterior Spinal Myelotomy for Intramedullary Hemorrhage Associated with Ependymoma or Cavernous Malformation of the High Cervical Spine
por: TSUJINO, Kohei, et al.
Publicado: (2022)

Occult neurohypophyseal germinoma discovered during the course of long-term diabetes insipidus: illustrative case
por: Yamada, Hironori, et al.
Publicado: (2023)

RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0b3kse49p96bt103raj01gmfau